Dare Bioscience (DARE)
(Delayed Data from NSDQ)
$0.44 USD
+0.01 (2.22%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $0.44 0.00 (0.39%) 7:04 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Dare Bioscience, Inc. [DARE]
Reports for Purchase
Showing records 161 - 180 ( 213 total )
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
3Q19 Marching Forward in Women''s Health, Led by Ovaprene and BV
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Win for Ovaprene PCT Opens the Door to a Single Pivotal Trial
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Dare Goes for Blue Tooth Drug Delivery, Set to Acquire Microchips Biotech and Picks up $5.7M
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from our Doc Call with Dr. Jane Schwebke
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Learn the ABC''s of BV on our Expert Call on Oct. 9th at 12PM ET
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare- Join Our Doc Call Series on Drug Pricing
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Earnings Recap: The More Analysis, The Merrier, Especially When Data-Driven
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
2Q19: Anticipation Is Building for Key 4Q19 Updates in BV1 and Ovaprene
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Reports the Quarter -Meaningful Milestones Ahead
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J